EichorEICHOR
Location: Marlton Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Marlton

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Hassman Research Institute Marlton Site · Bristol-Myers Squibb · NCT06929273Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Phase 1 · Atea Study Site · Atea Pharmaceuticals, Inc. · NCT07314346Drug Screening System Method Comparison
Phase N/A · CenExel HRI · Intelligent Bio Solutions Inc. · NCT06618183Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Phase 2 · Celen Medical Group Corp /ID# 234922 · AbbVie · NCT03339128A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Phase 1 · CenExel-HRI · Eli Lilly and Company · NCT06657768A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305
Phase 3 · Hassman Research Institute Marlton Site ( Site 2005) · Merck Sharp & Dohme LLC · NCT06655883An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Ma
Phase 2 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07288320Method Comparison of Intelligent Fingerprinting Drug Screening System
Phase N/A · CenExel Clinical Research · Intelligent Bio Solutions Inc. · NCT07650136A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Phase 3 · Hassman Research Institute, LLC · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06894212Left vs Left Randomized Clinical Trial
NA · Virtua Health · Baylor College of Medicine · NCT05650658Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Sympt
Phase 3 · Hassman Research Institute, LLC dba CenExel · Minerva Neurosciences · NCT07565428NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07114874A Study to Evaluate the Effect of KarXT on Urological Safety
Phase 4 · Hassman Research Institute Marlton Site · Bristol-Myers Squibb · NCT07221877Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed
NA · Virtua Health Inc. · Boston Scientific Corporation · NCT06735534NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06963034MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Premier Surgical Center · Stryker Instruments · NCT03072927Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Phase N/A · Medtronic · NCT00271180Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Phase N/A · Impulse Dynamics · Impulse Dynamics · NCT07209098Product Surveillance Registry
Phase N/A · Medtronic · NCT01524276Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
Phase 3 · Hassman Research Institute, LLC d/b/a CenExel Marlton, NJ · PleoPharma, Inc. · NCT07644052A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) In
Phase 2 · Clinical Research Integrity (CRI) Lifetree, LLC · Eccogene · NCT07288138A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Phase 3 · CenExel Marlton NJ · Janssen Research & Development, LLC · NCT07573176BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NA · Virtua Medical Group, P.A. · Orchestra BioMed, Inc · NCT06059638Integrity Implant System Post Market Clinical Follow-Up Study
NA · Virtua Health · Anika Therapeutics, Inc. · NCT06741527A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Phase 1 · Hassman Research Institute Marlton Site · Bristol-Myers Squibb · NCT07061288A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2
Phase 3 · Hassman Research Institute Marlton Site · Bristol-Myers Squibb · NCT06951711A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NA · Virtua Health, Inc. · Cleerly, Inc. · NCT06112418Serranator POINT FORCE Registry
Phase N/A · Virtua Health · Cagent Vascular LLC · NCT06687590A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult P
Phase 2 · Cenexel Hassman Research Institute (Hri) /ID# 276128 · AbbVie · NCT07145918Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Phase 3 · Virtua Health Incorporated · Amgen · NCT07037459
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.